Target Name: ALX3
NCBI ID: G257
Review Report on ALX3 Target / Biomarker Content of Review Report on ALX3 Target / Biomarker
ALX3
Other Name(s): aristaless-like homeobox 3 | MGC138212 | Homeobox protein aristaless-like 3 | proline-rich transcription factor ALX3 | FND | Aristaless-like homeobox 3 | ALX homeobox 3 | FND1 | frontonasal dysplasia | OTTHUMP00000013372 | Proline-rich transcription factor ALX3 | ALX3_HUMAN | MGC141988

ALX3: A Potential Drug Target Or Biomarker

ALX3, also known as Aristaless-like homeobox 3, is a protein that is expressed in a variety of tissues throughout the body. It is a member of the homeobox gene family, which is known for the development and maintenance of tissues during development and development . ALX3 is highly conserved across various species, and has been identified as a potential drug target or biomarker.

The homeobox gene family plays a crucial role in the development and maintenance of various tissues in the body. These genes are responsible for the production of transcription factors, which are proteins that help to regulate gene expression. During development, the homeobox genes are involved in the formation and organization of tissues, and are thought to be important for the development of specific tissues such as limbs, hearts, and kidneys.

ALX3 is a member of the homeobox gene family that is highly conserved across various species. It is found in a variety of organisms, including bacteria, archaea, and eukaryotes. ALX3 is expressed in a variety of tissues throughout the body, including the brain, heart, and kidneys.

One of the key functions of ALX3 is its role in the development and maintenance of the nervous system. ALX3 is highly expressed in the brain, and has been implicated in the development and maintenance of neural stem cells. It is also involved in the production of neurotransmitters, such as dopamine and GABA, which are important for the functioning of the nervous system.

In addition to its role in the nervous system, ALX3 is also involved in the development and maintenance of other tissues. For example, it is highly expressed in the heart, and has been implicated in the development and maintenance of heart muscle. It is also involved in the production of growth factors, which are important for the growth and development of tissues.

As a potential drug target or biomarker, ALX3 is attracting a lot of interest due to its role in the development and maintenance of various tissues. Its ability to regulate gene expression and participate in the development and maintenance of tissues makes it an attractive target for drug development. Additionally, its conservation across various species and its expression in a variety of tissues make it a valuable biomarker for diagnostic and therapeutic applications.

In conclusion, ALX3 is a highly conserved protein that is involved in the development and maintenance of various tissues throughout the body. Its role in the nervous system and its expression in a variety of tissues make it an attractive target for drug development. Additionally, its conservation across various species and its expression in a variety of tissues make it a valuable biomarker for diagnostic and therapeutic applications. Further research is needed to fully understand the role of ALX3 in the development and maintenance of tissues, as well as its potential as a drug target or biomarker.

Protein Name: ALX Homeobox 3

Functions: Transcriptional regulator with a possible role in patterning of mesoderm during development

The "ALX3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ALX3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ALX4 | ALYREF | AMACR | AMBN | AMBP | AMBRA1 | AMD1 | AMD1P2 | AMDHD1 | AMDHD2 | AMELX | AMELY | AMER1 | AMER2 | AMER3 | AMFR | AMH | AMHR2 | AMIGO1 | AMIGO2 | AMIGO3 | Amine oxidase (copper containing) | Amino acid hydroxylase | Aminoacyl-tRNA Synthetase Complex | AMMECR1 | AMMECR1L | AMN | AMN1 | AMOT | AMOTL1 | AMOTL2 | AMP Deaminase | AMP-activated protein kinase (AMPK) | AMP-activated protein kinase alpha1beta1gamma1 | AMP-activated protein kinase alpha2beta1gamma1 | AMP-activated protein kinase alpha2beta1gamma2 | AMP-activated protein kinase alpha2beta2gamma2 | AMPD1 | AMPD2 | AMPD3 | AMPH | AMT | AMTN | AMY1A | AMY1B | AMY1C | AMY2A | AMY2B | Amylin receptor | Amyloid beta A4 precursor protein-binding family (APP-BP) | AMZ1 | AMZ2 | AMZ2P1 | Anandamide membrane transporter (AMT) | ANAPC1 | ANAPC10 | ANAPC10P1 | ANAPC11 | ANAPC13 | ANAPC15 | ANAPC16 | ANAPC1P1 | ANAPC1P2 | ANAPC2 | ANAPC4 | ANAPC5 | ANAPC7 | ANG | ANGEL1 | ANGEL2 | Angiogenic Factor | Angiotensin receptor (AT) | ANGPT1 | ANGPT2 | ANGPT4 | ANGPTL1 | ANGPTL2 | ANGPTL3 | ANGPTL4 | ANGPTL5 | ANGPTL6 | ANGPTL7 | ANGPTL8 | ANHX | ANK1 | ANK2 | ANK3 | ANKAR | ANKDD1A | ANKDD1B | ANKEF1 | ANKFN1 | ANKFY1 | ANKH | ANKHD1 | ANKHD1-EIF4EBP3 | ANKIB1 | ANKK1 | ANKLE1 | ANKLE2